Welcome to our dedicated page for Phibro Animal news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal stock.
Phibro Animal Health Corporation reports developments in animal health, mineral nutrition and performance products for food-animal markets. The company develops, manufactures and markets antibacterials, anticoccidials, nutritional specialty products, vaccines and mineral nutrition products for poultry, swine, beef and dairy cattle, and aquaculture in the United States and international markets.
Recurring PAHC news includes quarterly results and guidance, cash dividend declarations on Class A and Class B common stock, investor conference participation and regulatory updates affecting antimicrobial products such as virginiamycin and bacitracin. Company updates also address product portfolio activity, acquisition-related effects, input and distribution costs, foreign-currency impacts and tools such as PhibroVet for veterinary prescription management.
Phibro Animal Health Corporation (NASDAQ:PAHC) will announce its third quarter financial results on May 6, 2021, after market close. A conference call and webcast will follow on May 7, 2021, at 9:00 AM Eastern Time. Interested parties can access the call via phone or online, with a replay available two hours post-event. Phibro specializes in developing and supplying a range of animal health and mineral nutrition products aimed at supporting livestock health and sustainability. For details, visit investors.pahc.com.
Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the Bank of America Securities 2021 Virtual Healthcare Conference. The event is scheduled for Tuesday, May 11, 2021, at 4:15 PM ET. Key executives including Chairman and CEO Jack Bendheim, CFO Damian Finio, and Executive VP Daniel Bendheim will address analysts and investors. The live audio presentation will be accessible on the Phibro Investor Relations Website, with a replay available post-event.
Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the Barclays Virtual Global Healthcare Conference on March 10, 2021, at 3:35 PM Eastern Time. The company's Chairman and CEO, Jack Bendheim, along with CFO Damian Finio, will address financial analysts and investors during the session. Interested parties can access the live audio presentation on the Phibro Investor Relations Website, with a replay available afterward. Phibro focuses on animal health and mineral nutrition products to support sustainable livestock practices.
Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the Bank of America Merrill Lynch 2021 Virtual Animal Health Summit on February 25, 2021. During the event, Chairman Jack Bendheim and CFO Damian Finio will address financial analysts and investors at 12:40 PM Eastern Time. The live audio presentation can be accessed on the company's Investor Relations website, with an archived replay available afterward. Phibro focuses on animal health and nutrition products, aimed at supporting sustainable livestock production.
Phibro Animal Health Corporation (NASDAQ:PAHC) reported its second-quarter financial results for the period ending December 31, 2020. Net sales reached $206 million, down 4% from the previous year, while net income improved to $13 million, an 8% increase. Diluted EPS increased by 10% to $0.32. The company noted challenges in international demand, particularly in China and Latin America. Despite sales declines, gross profit slightly improved. For Q3 2021, Phibro projects net sales between $205-208 million and net income of $11-12 million.
The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. This dividend will be payable on March 24, 2021, to stockholders of record as of the close of business on March 3, 2021. The company focuses on developing and supplying animal health and nutrition products, assisting veterinarians and farmers in producing healthy food sustainably.
Phibro Animal Health Corporation (NASDAQ: PAHC) is set to release its second-quarter financial results on February 3, 2021, post-market close. A conference call and webcast will follow on February 4, 2021, at 9:00 AM ET, allowing stakeholders to engage with management. Interested parties can access the presentation via their investor relations website. Phibro focuses on providing a diverse range of animal health and mineral nutrition products, supporting sustainable food production with fewer natural resources.
Phibro Animal Health Corporation (NASDAQ:PAHC) reported its Q1 2020 results with net sales of $195 million, a 3% increase year-over-year and net income rising to $12 million, up from $2.5 million. Diluted EPS reached $0.30, an increase of $0.24. The company noted strong performance in its core Animal Health segment, particularly in nutritional specialty products and vaccines, while Mineral Nutrition saw a decline. The outlook for Q2 forecasts net sales of about $205 million, reflecting ongoing recovery in the animal production industry.
Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on November 11, 2020, at 1:15 PM ET. Key executives, including Chairman and CEO Jack Bendheim, CFO Richard Johnson, and incoming CFO Damian Finio, will address financial analysts and investors. The presentation will be available live on the company’s Investor Relations Website, with a replay archived for later access. Phibro focuses on developing and supplying animal health and nutrition products to support healthy food production.
Phibro Animal Health Corporation (NASDAQ:PAHC) will release its first quarter financial results on November 4, 2020, after market close. A conference call and webcast are scheduled for November 5, 2020, at 9:00 AM ET.
Investors can participate in the call via phone or through a webcast available on the company's investor relations website. A replay will be accessible two hours after the live event. Phibro develops and supplies a wide range of animal health and nutrition products to support sustainable livestock production.